dc.creator | Guzmán M.A. | |
dc.creator | Olguín M.A. | |
dc.creator | Gronhert M.O. | |
dc.date.accessioned | 2020-09-02T22:19:50Z | |
dc.date.accessioned | 2022-11-08T20:19:31Z | |
dc.date.available | 2020-09-02T22:19:50Z | |
dc.date.available | 2022-11-08T20:19:31Z | |
dc.date.created | 2020-09-02T22:19:50Z | |
dc.date.issued | 2015 | |
dc.identifier | 31, 3, 1129-1133 | |
dc.identifier | 02121611 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4771 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143209 | |
dc.language | en | |
dc.publisher | Grupo Aula Medica S.A. | |
dc.subject | AGEs | |
dc.subject | Glycemic control | |
dc.subject | Inflammation | |
dc.subject | TXNIP | |
dc.subject | β-cell function | |
dc.subject | Callithrix | |
dc.subject | 8-epi-prostaglandin F2alpha | |
dc.subject | advanced glycation end product | |
dc.subject | antidiabetic agent | |
dc.subject | carrier protein | |
dc.subject | glucose blood level | |
dc.subject | glycosylated hemoglobin | |
dc.subject | IL6 protein, human | |
dc.subject | insulin | |
dc.subject | interleukin 1beta | |
dc.subject | interleukin 6 | |
dc.subject | lipid | |
dc.subject | prostaglandin F2 alpha | |
dc.subject | thiobarbituric acid reactive substance | |
dc.subject | tumor necrosis factor alpha | |
dc.subject | TXNIP protein, human | |
dc.subject | adult | |
dc.subject | analogs and derivatives | |
dc.subject | analysis | |
dc.subject | anthropometry | |
dc.subject | blood | |
dc.subject | body mass | |
dc.subject | body weight | |
dc.subject | complication | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | female | |
dc.subject | genetics | |
dc.subject | glucose blood level | |
dc.subject | human | |
dc.subject | inflammation | |
dc.subject | male | |
dc.subject | middle aged | |
dc.subject | obesity | |
dc.subject | oxidative stress | |
dc.subject | Adult | |
dc.subject | Anthropometry | |
dc.subject | Blood Glucose | |
dc.subject | Body Mass Index | |
dc.subject | Body Weight | |
dc.subject | Carrier Proteins | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | Dinoprost | |
dc.subject | Female | |
dc.subject | Glycosylation End Products, Advanced | |
dc.subject | Hemoglobin A, Glycosylated | |
dc.subject | Humans | |
dc.subject | Hypoglycemic Agents | |
dc.subject | Inflammation | |
dc.subject | Insulin | |
dc.subject | Interleukin-1beta | |
dc.subject | Interleukin-6 | |
dc.subject | Lipids | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Overweight | |
dc.subject | Oxidative Stress | |
dc.subject | Thiobarbituric Acid Reactive Substances | |
dc.subject | Tumor Necrosis Factor-alpha | |
dc.title | Glycemic control and oxidative stress markers and their relationship with the thioredoxin interacting protein (Txnip) gene in type 2 diabetic patients [Control Glicémico Y Marcadores De Estrés Oxidativo Y Su Relación Con El Gen De La Proteína Interactuante Con La Tioredoxina (Txnip) En Sujetos Diabéticos Tipo 2] | |
dc.type | Article | |